Drug Shortage Report for TRASYLOL
| Report ID | 3779 |
| Drug Identification Number | 02186845 |
| Brand name | TRASYLOL |
| Common or Proper name | APROTININ (BOVINE) |
| Company Name | NORDIC GROUP B.V. |
| Market Status | DORMANT |
| Active Ingredient(s) | APROTININ |
| Strength(s) | 10000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 50 ML VIAL (500,000 KIU); 200 ML VIAL (2,000,000 KIU) |
| ATC code | B02AB |
| ATC description | ANTIFIBRINOLYTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2014-10-30 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2017-10-13 |
| Company comments | Canadian responsibility for Trasylol (aprotinin) now resides with Nordic Group B.V. (represented in Canada by Methapharm Inc.). For all inquiries, please contact Methapharm Medical Affairs at medinfo@methapharm.com, phone: 1-800-287-7686 ext 7804, or by fax: (519) 751-9149 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | SIRIUSDREEF 41 HOOFDDORP, NOORD-HOLLAND NETHERLANDS 2132 WT |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-03-21 | French | Compare |
| v1 | 2017-03-21 | English | Compare |
Showing 1 to 2 of 2